Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis
Public ClinicalTrials.gov record NCT01358240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Vehicle Controlled, Parallel Group Comparison of Econazole Nitrate Foam 1% vs Foam Vehicle and an Evaluator-Blinded Comparison of Econazole Nitrate Foam 1% and Econazole Nitrate Cream 1% in Subjects With Interdigital Tinea Pedis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study of the safety and efficacy of Econazole Nitrate Foam 1% and the Foam Vehicle in subjects with interdigital tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 4 week treatment period and a 2 week follow-up evaluation. The study will also utilize Econazole Nitrate Cream 1% (for safety comparison) and a Placebo cream for blinding purposes only.
Study identification
- NCT ID
- NCT01358240
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 336 participants
Conditions and interventions
Conditions
Interventions
- Econazole Nitrate Foam 1% Drug
- Vehicle Foam Drug
- Econazole Nitrate Cream 1% Drug
- Placebo Cream Other
Drug · Other
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2011 (Type not available)
- Primary completion
- Apr 2012 (Actual)
- Completion
- Aug 2012 (Actual)
- Last update posted
- Sep 28, 2012
2011 – 2012
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sunil S. Dhawan, MD | Fremont | California | 94538 | — |
| Guy F. Webster, MD, PhD | Hockessin | Delaware | 19707 | — |
| Marta I. Rendon, MD | Boca Raton | Florida | 33486 | — |
| Jonathan Kantor, MD | Jacksonville | Florida | 32204 | — |
| Steven E. Kempers, MD | Fridley | Minnesota | 55432 | — |
| Joel Schlessinger, MD | Omaha | Nebraska | 68144 | — |
| Phoebe Rich, MD | Portland | Oregon | 97210 | — |
| Edward J. Primka III, MD | Knoxville | Tennessee | 37917 | — |
| Michael T. Jarratt, MD | Austin | Texas | 78759 | — |
| William Abramovits, MD | Dallas | Texas | 75230 | — |
| David M. Pariser, MD, FAAD, FACP | Norfolk | Virginia | 23507 | — |
| Harry H. Sharata, MD, PhD | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01358240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2012 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01358240 live on ClinicalTrials.gov.